ArticleJournal of cancer epidemiology2012

Impact on Medical Cost, Cumulative Survival, and Cost-Effectiveness of Adding Rituximab to First-Line Chemotherapy for Follicular Lymphoma in Elderly Patients: An Observational Cohort Study Based on SEER-Medicare.

Robert I Griffiths et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.